Candid Therapeutics
Healthcare & Life Sciences
Recent Finacing
Equity
Recent Raise
$370M
Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.
Focus Areas
Biotechnology
autoimmune therapies
bispecific T-cell engager antibodies
oncology
Phase 1 results
life sciences.
Investors
